Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
To date, there are no clinically effective neuroprotective or disease-modifying treatments that can halt Parkinson's disease (PD) progression. The current clinical approach focuses on symptomatic management. This failure may relate to the complex neurobiology underpinning the development of PD and t...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020-06-01
|
| Col·lecció: | Frontiers in Neurology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/article/10.3389/fneur.2020.00556/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|